Skip to main content

Table 3 Five- and 10-year-period relative survival for patients with CLL in 2009–2011

From: Trends in survival of chronic lymphocytic leukemia patients in Germany and the USA in the first decade of the twenty-first century

  5-year RS (SE) Germany 5-year RS (SE) USA Difference p (country) 10-year RS (SE) Germany 10-year RS (SE) USA Difference p (country)
Alla 80.2 (0.8) 82.4 (0.7) −2.2 0.09 59.5 (1.3) 64.7 (1.1) −5.2 0.0001
Gender         
 Malea 78.4 (1.0) 81.4 (1.0) −3.0 0.07 57.4 (1.8) 63.0 (1.5) −5.6 0.0001
 Femalea 82.9 (1.1) 84.2 (1.0) −1.3 0.7 63.6 (1.8) 67.9 (1.6) −4.3 0.1
Age group         
 15–44 93.4 (2.5) 91.4 (3.1) +2.0 0.7 78.4 (4.4) 75.9 (4.6) +2.5 0.7
 45–54 91.5 (1.6) 95.1 (1.2) −3.6 0.1 72.9 (2.7) 83.1 (2.1) −10.2 0.007
 55–64 85.9 (1.3) 88.7 (1.1) −2.8 0.2 64.9 (1.9) 71.8 (1.8) −6.9 0.009
 65–74 81.7 (1.2) 83.2 (1.3) −1.5 0.6 59.4 (1.9) 64.6 (1.9) −5.2 0.08
 75+ 65.1 (1.9) 69.3 (1.6) −4.2 0.8 42.6 (3.1) 49.0 (2.4) −6.4 0.4
Males         
 15–44 95.7 (2.5) 90.3 (4.3) +2.4 0.3 78.2 (5.6) 72.0 (6.0) +6.2 0.4
 45–54 89.9 (2.1) 94.5 (1.7) −4.6 0.09 68.8 (3.7) 79.4 (2.8) −10.6 0.04
 55–64 84.8 (1.7) 86.9 (1.5) −2.1 0.4 59.1 (2.5) 70.1 (2.2) −11.0 0.005
 65–74 79.2 (1.6) 81.5 (1.7) −2.3 0.5 56.7 (2.6) 61.7 (2.5) −5.0 0.2
 75+ 62.1 (2.7) 69.2 (2.3) −7.1 0.4 44.6 (4.9) 49.7 (3.5) −5.1 0.3
Females         
 15–44 88.0 (5.9) 92.3 (4.7) −4.3 0.6 77.5 (7.5) 81.5 (7.1) −4.0 0.6
 45–54 94.9 (2.2) 96.2 (1.8) −1.3 0.6 79.3 (4.0) 89.9 (2.9) −10.6 0.05
 55–64 87.9 (2.0) 91.7 (1.6) −3.8 0.2 74.1 (2.8) 74.5 (2.9) −0.4 0.6
 65–74 85.8 (1.7) 86.1 (2.0) −0.3 0.9 63.8 (2.9) 69.5 (2.9) −5.7 0.3
 75+ 68.3 (2.6) 69.4 (2.3) −1.1 0.6 42.8 (4.1) 48.6 (3.2) −5.8 0.8
  1. RS relative survival, SE standard error, p (country) p value for comparison between the USA and Germany
  2. aAge adjusted